Philadelphia Jury Orders GSK To Pay $2.5M For Paxil Birth Defect Injuries

GlaxoSmithKline must pay $2.5 million to a Philadelphia plaintiff after a jury found that its antidepressant drug Paxil caused a serious hearth birth defect. The plaintiff’s four year old son was born with several heart defects. The child spent months in the hospital and has had several surgeries, with more to come. The plaintiffs argued […]

GlaxoSmithKline must pay $2.5 million to a Philadelphia plaintiff after a jury found that its antidepressant drug Paxil caused a serious hearth birth defect.

The plaintiff’s four year old son was born with several heart defects. The child spent months in the hospital and has had several surgeries, with more to come. The plaintiffs argued that these defects were caused by her use of Paxil during her pregnancy. The jury found that Paxil did not warn of the potential for these birth effects while taking the drug early in a pregnancy (and still hasn’t admitted the link).

There are hundreds more cases against GlaxoSmithKline that are working their way through the courts, and this first verdict will undoubtedly encourage additional plaintiffs to come forward. Although the $2.5 million settlement is relatively small when compared to the nearly $1 billion per year in revenue Paxil brings in, legal observers were watching this case closely, as any loss or win would have a direct impact on both settlement expectations in related cases as well as the likelihood of other potential victims to bring suit.

 

Leave a Reply

 

Anti-Spam Protection by WP-SpamFree




Follow Us on:

Contact Us

Privacy Policy

Please click here to view our privacy policy.